Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common
-
Shares outstanding
-
49,594,356
-
Total 13F shares
-
3,145,587
-
Share change
-
+74,272
-
Total reported value
-
$14,312,158
-
Price per share
-
$4.55
-
Number of holders
-
29
-
Value change
-
+$1,628,141
-
Number of buys
-
19
-
Number of sells
-
12
Institutional Holders of PDS Biotechnology Corp - Common (PDSB) as of Q1 2021
As of 31 Mar 2021,
PDS Biotechnology Corp - Common (PDSB) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,145,587 shares.
The largest 10 holders included
VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Ikarian Capital, LLC, INSPIRION WEALTH ADVISORS, LLC, GEODE CAPITAL MANAGEMENT, LLC, FIRST MANHATTAN CO, Sofinnova Investments, Inc., New Leaf Venture Partners, L.L.C., Minot Wealth Management LLC, and MARSHALL WACE, LLP.
This page lists
29
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.